Inogen’s second quarter revenues, profits way up
Inogen revenues increased 24 percent and profits increased 48 percent, the company said when it released second quarter earnings results Aug. 4 Revenues for the Goleta-based maker of direct-to-consumer respiratory products increased 24 percent from $44 million during the second quarter of 2015 to $54.57 million in 2016, beating analyst revenue estimates of $52.44, million Read More →
Read More →Teledyne’s second quarter revenues, profits, earnings per share down
Teledyne Technology revenues fell, profits fell and earnings per share fell during the second quarter, the company announced when it released second quarter earnings results Aug. 4. The Thousand Oaks-based industrial conglomerate saw second quarter revenues fall 6.7 percent from $573.6 million in 2015 to $534.9 million in 2016, which missed analyst estimates of $546.7 Read More →
Read More →Inphi completes sale of Rambus
Inphi completed the sale of its memory product business to Sunnyvale-based Rambus Aug. 4. The Santa Clara-based Inphi, which designs chips aimed at packing more memory onto Internet servers and increasing bandwidth, employs a large engineering force in Thousand Oaks. The sale will allow it to focus on its communications business. As part of the Read More →
Read More →PennyMac Financial beats analyst estimates for second quarter
Westlake Village-based PennyMac Financial Services reported a net income of $74.3 million for the second quarter of 2016 on revenue of $207.8 million, exceeding analyst projection on earnings per share and revenue. PennyMac Financial, which was founded by former Countrywide Financial Services executives after that company was acquired by Bank of America, reported earnings of Read More →
Read More →Goleta-based Yardi Systems has 5,000 employees
Goleta-based Yardi Systems said Aug. 4 that it now has 5,000 employees. Yardi, a software developer that makes software and apps for small and large real estate managers, said in a news release it hired its 5,000th employee and now has large offices in India, Romania and Canada. The company provides tenant-management software for some Read More →
Read More →CVS Health will not cover Amgen’s Neupogen in favor of Novartis biosimilar
CVS Health will no longer cover Thousand Oaks-based Amgen’s Neupogen on its standard drug plan in 2017, favoring the biosimilar Zarxio from Novartis. CVS, which is the second largest benefits manager behind Express Scripts and also owns the largest chain of drug stores in the U.S., said Aug. 2 it will choose biosimilar drugs over Read More →
Read More →